Isorhamnetin can effectively restore the depletion levels of Nrf2, BDNF, and HO-1 in the cerebral cortex caused by LPS-induced depression, thus enhancing the therapeutic effect of the conventional antidepressant escitalopram (Gammoh et al., 2023). The gene discussed is BDNF; the disease is major depressive disorder.